chondrosarcoma: A malignant cartilaginous matrix-producing mesenchymal neoplasm arising from the bone and soft tissue. It usually affects middle-aged to elderly adults. The pelvic bones, ribs, shoulder girdle, and long bones are the most common sites of involvement. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion.
Benign neoplasm of bone and articular cartilage
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_BONE_CARTILAGE
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
2424 |
4. Check minimum number of eventsNone |
2424 |
5. Include endpoints |
3415 |
6. Filter based on genotype QC (FinnGen only) |
3415 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasma benignum ossis sive cartilaginis articularis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm of bone and articular cartilage
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of bone and articular cartilage
- Benign neoplasms
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 27315 | 13494 | 13693 |
| Only index persons | 25120 | 12600 | 12520 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.38 | 0.39 | 0.38 |
| Only index persons | 0.47 | 0.46 | 0.48 |
| Median age at first event (years) | |||
| Whole population | 31.98 | 37.34 | 26.57 |
| Only index persons | 30.96 | 36.54 | 25.35 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3415 | 2042 | 1373 |
| Unadjusted period prevalence (%) | 0.66 | 0.70 | 0.61 |
| Median age at first event (years) | 40.09 | 40.27 | 39.82 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3060
- Matched controls
- 30599
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
59.4
323.0
390
75
D16.1
ICD-10 Finland
Benign neoplasm: Short bones of upper limb
+∞
323.0
377
*
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
10431.2
323.0
792
*
D16.49
ICD-10 Finland
Bones of skull and face
+∞
245.1
232
*
D16.0
ICD-10 Finland
Benign neoplasm: Scapula and long bones of upper limb
+∞
237.6
225
*
9102
FHL
Trepanation or removal of the local bone process
64.5
233.0
271
46
D16.3
ICD-10 Finland
Benign neoplasm: Short bones of lower limb
+∞
200.2
190
*
21306
ICD-8 Finland
Benign neoplasm of bone and cartilage, Ossium longorum extremitatis inferioris
+∞
198.1
188
*
2137A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Long bones of lower limb
+∞
165.1
157
*
D16.90
ICD-10 Finland
Bone and articular cartilage, unspecified
1548.6
150.2
145
*
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
16.2
119.5
198
130
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
297.6
112.8
114
*
21307
ICD-8 Finland
Benign neoplasm of bone and cartilage, Ossium brevium extremitatis inferioris
+∞
93.2
89
*
D16.8
ICD-10 Finland
Benign neoplasm: Pelvic bones, sacrum and coccyx
+∞
89.0
85
*
2135A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Short bones of upper limb
+∞
86.9
83
*
21303
ICD-8 Finland
Benign neoplasm of bone and cartilage, Ossium longorum extremitatis superioris et scapulae
+∞
83.7
80
*
NHR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of ankle or foot
60.1
70.0
82
14
AAP10
NOMESCO Finland
Extirpation of a skull lesion
349.9
68.8
69
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
52.6
64.3
77
15
2138A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Short bones of lower limb
+∞
61.7
59
*
D16.6
ICD-10 Finland
Benign neoplasm: Vertebral column
+∞
59.6
57
*
21304
ICD-8 Finland
Benign neoplasm of bone and cartilage, Ossium brevium extremitatis superioris
+∞
58.5
56
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
34.0
55.9
73
22
D16.50
ICD-10 Finland
Benign tumor of the mandibular bone or cartilage
+∞
54.3
52
*
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
6.2
52.4
146
244
D16.51
ICD-10 Finland
Benign tumor of the mandibular bone with urpsrung in teeth
506.1
50.6
50
*
D16.7
ICD-10 Finland
Benign neoplasm: Ribs, sternum and clavicle
+∞
45.9
44
*
21309
ICD-8 Finland
Benign neoplasm of bone and cartilage, Unspecified
+∞
43.8
42
*
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
24.4
42.4
60
25
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
38.5
41.9
53
14
2130A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Bones of skull and face
+∞
37.6
36
*
D16.40
ICD-10 Finland
Orbital bone
+∞
36.5
35
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
5.1
35.1
114
230
21308
ICD-8 Finland
Benign neoplasm of bone and cartilage, Loco alio sive multiplici
+∞
33.4
32
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
4.9
32.5
109
228
2134A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Scapula and long bones of upper limb
+∞
32.3
31
*
9101
FHL
Bone biopsy
26.2
31.9
44
17
N02AX02
ATC
tramadol; systemic, rectal
1.6
31.7
1170
8503
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.2
31.4
351
1709
NF3AA
NOMESCO Finland
Femur X-ray examination
5.7
30.5
90
163
D16
ICD-10 Finland
Benign neoplasm of bone and articular cartilage
+∞
27.1
26
*
9104
FHL
Autogenous bone graft
38.2
27.1
34
9
M79.6
ICD-10 Finland
Pain in limb
1.6
26.1
974
7011
N03AX16
ATC
pregabalin; oral
1.7
26.0
646
4172
NDK10
NOMESCO Finland
Incision or excision of a bone of hand
22.0
25.6
37
17
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
25.4
1309
10134
N02BE01
ATC
paracetamol; systemic, rectal
1.6
25.4
2460
21942
M25.5
ICD-10 Finland
Pain in joint
1.6
25.3
829
5764
21302
ICD-8 Finland
Benign neoplasm of bone and cartilage, Costae, sterni, claviculae
+∞
25.0
24
*
M01AH05
ATC
etoricoxib; oral
1.5
24.4
1675
13745
NGK05
NOMESCO Finland
Partial or total excision of bone of lower leg
34.8
24.3
31
9
21300
ICD-8 Finland
Benign neoplasm of bone and cartilage, Mandibulae (detibus inclusis)
+∞
24.0
23
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.1
23.6
278
1378
9103
FHL
Partial or complete bone removal
17.2
21.8
34
20
NFK10
NOMESCO Finland
Fenestration or partial or total excision of bone of femur
50.4
21.1
25
5
M85.4
ICD-10 Finland
Solitary bone cyst
34.0
21.1
27
8
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
3.7
20.3
89
244
ZXA05
NOMESCO Finland
Left side
1.6
20.1
639
4369
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.7
20.1
490
3124
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
6.2
20.0
54
89
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
11.3
19.9
37
33
2139X
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Bone and articular cartilage, site unspecified
+∞
19.8
19
*
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
4.6
19.3
68
152
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
19.1
2671
24727
EFA10
NOMESCO Finland
Excision of lesion of jaws
34.5
18.9
24
7
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
18.7
1058
8191
ZZH40
NOMESCO Finland
Substitute of bone
5.7
18.6
53
94
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
18.5
1026
7911
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
17.9
718
5170
AA1AD
NOMESCO Finland
CT of head and brain
1.6
17.4
571
3923
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
3.1
17.3
99
331
ZXA00
NOMESCO Finland
Right side
1.5
17.3
668
4758
NG1DG
NOMESCO Finland
Knee and lower leg very extensive MRI examination with high intensity magnet
12.0
17.3
31
26
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.0
17.3
227
1175
21305
ICD-8 Finland
Benign neoplasm of bone and cartilage, Pelvis, sacri, coccygis
+∞
16.7
16
*
C40.22
ICD-10 Finland
Chondrosarcoma of the long bones of the lower extremity
170.9
16.5
17
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
16.5
964
7467
N06AX21
ATC
duloxetine; oral
1.8
16.4
303
1769
S18
ICPC
Laceration/cut
1.4
16.1
1048
8269
Q78.6
ICD-10 Finland
Multiple congenital exostoses
47.7
16.0
19
*
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.5
15.9
582
4092
J01DB01
ATC
cefalexin; oral
1.4
15.8
2353
21387
M54.5
ICD-10 Finland
Low back pain
1.4
15.8
879
6738
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
2.4
15.7
134
572
WX320
NOMESCO Finland
Spinalanesthesy
1.5
15.7
565
3952
NHK10
NOMESCO Finland
Incision or excision of metatarsal or tarsal bone
4.9
15.7
51
106
2131A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Lower jaw bone
+∞
15.6
15
*
Q78.48
ICD-10 Finland
Enchondromatosis
+∞
15.6
15
*
R01AD09
ATC
mometasone; nasal
1.4
15.5
1233
10060
NF1AA
NOMESCO Finland
Hip X-ray examination
2.0
15.5
203
1050
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.9
15.4
241
1332
J01DA01
ATC
[U] cefalexin; systemic
1.4
15.4
1728
14916
EDA10
NOMESCO Finland
Biopsy of mandible
13.1
15.2
26
20
M03BX02
ATC
tizanidine; oral
1.4
15.0
1740
15071
NDK99
NOMESCO Finland
Other operation on bone of hand or wrist
10.9
15.0
28
26
SPAT1153
SPAT
Removal of sutures
1.4
14.9
787
5959
N03AX12
ATC
gabapentin; oral
1.6
14.9
393
2548
M01AE02
ATC
naproxen; oral, rectal
1.4
14.9
1568
13364
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
3.8
14.8
62
165
NER20
NOMESCO Finland
Incomplete excision of soft tissue tumour of pelvis
31.8
14.8
19
6
ND1CG
NOMESCO Finland
Wrist and hand extensive MRI examination with high intensity magnet
5.4
14.6
43
80
2136A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Pelvic bones, sacrum and coccyx
+∞
14.6
14
*
D16.41
ICD-10 Finland
Benign tumor of the maxillary bone originating in teeth
+∞
14.6
14
*
D16.5
ICD-10 Finland
Benign neoplasm: Lower jaw bone
+∞
14.6
14
*
A02BC02
ATC
pantoprazole; systemic
1.4
14.5
1703
14738
J01AA02
ATC
doxycycline; systemic
1.4
14.4
2140
19226
NG4AA
NOMESCO Finland
Lower leg X-ray examination
2.8
13.9
91
335
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
13.9
332
2092
X58
ICD-10 Finland
Exposure to other specified factors
1.6
13.9
381
2495
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
3.7
13.8
59
160
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
13.7
697
5224
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
13.7
1399
11809
21301
ICD-8 Finland
Benign neoplasm of bone and cartilage, Columnae vertebralis (sacro et coccyge exclusis)
+∞
13.5
13
*
R51.80
ICD-10 Finland
Headache
1.6
13.5
398
2647
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.7
13.4
296
1825
NG1AD
NOMESCO Finland
Knee CT examination
4.3
13.4
49
116
NDR30
NOMESCO Finland
Complete excision of soft tissue tumour of wrist or hand
10.5
12.7
24
23
C40.20
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity without histology
70.1
12.6
14
*
J01FF01
ATC
clindamycin; systemic
1.4
12.5
687
5210
NK6DT
NOMESCO Finland
Bone biopsy with MRI guidance
+∞
12.5
12
*
M67.4
ICD-10 Finland
Ganglion
1.9
12.4
175
931
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
12.4
852
6722
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
12.4
946
7595
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.6
12.3
360
2393
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.7
12.2
290
1824
P01AB01
ATC
metronidazole; oral, rectal
1.3
12.2
1034
8433
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.0
12.1
163
853
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
2.8
12.0
77
282
M01AB05
ATC
diclofenac; systemic, rectal
1.3
12.0
1810
16036
NFK99
NOMESCO Finland
Other operation on bone of femur
21.4
12.0
17
8
UKC02
NOMESCO Finland
Cystoscopy
1.6
11.8
331
2173
WX204
NOMESCO Finland
Axillary plexus blockaced
2.5
11.8
93
383
J01FA09
ATC
clarithromycin; systemic
1.4
11.8
835
6609
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
11.8
215
1250
A02BC05
ATC
esomeprazole; systemic
1.3
11.8
1029
8418
R01AD12
ATC
fluticasone furoate; nasal
1.4
11.8
800
6290
R52.9
ICD-10 Finland
Pain, unspecified
1.8
11.6
203
1165
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
11.5
204
1177
2133A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Ribs, sternum and clavicle
+∞
11.5
11
*
9220/3-C40.2
ICD-O-3
Chondrosarcoma, NOS, of long bones of lower limb and associated joints
+∞
11.5
11
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
11.4
249
1531
9109
FHL
Other measure in this category
15.1
11.3
18
12
SPAT1263
SPAT
Sampling
1.3
11.3
1095
9082
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.4
11.3
685
5278
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
11.0
616
4677
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.5
11.0
87
359
L03
ICPC
Low back symptom/complaint
1.4
10.9
595
4501
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
10.8
1313
11222
2392A
ICD-9 Finland
Neoplasm of unspecified nature, Bone, soft tissue and skin
8.9
10.7
22
25
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.6
10.6
251
1577
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
10.6
1450
12574
L08
ICPC
Shoulder symptom/complaint
1.5
10.6
437
3127
WX110
NOMESCO Finland
Local anesthesy
1.3
10.5
1922
17313
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
10.5
578
4368
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
10.5
248
1556
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
10.5
477
3482
J01FA10
ATC
azithromycin; systemic
1.3
10.5
1623
14300
75665
ICD-8 Finland
Other congenital anomalies of musculoskeletal system, Exostosis cartilaginea multiplex
110.4
10.4
11
*
R01AD08
ATC
fluticasone; nasal
1.4
10.3
740
5845
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
10.3
1498
13080
SPAT1229
SPAT
Assessment of need for aid
1.8
10.3
164
917
M01AH01
ATC
celecoxib; oral (coxibs)
1.5
10.2
423
3028
M85.6
ICD-10 Finland
Other cyst of bone
23.4
10.2
14
6
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
10.2
219
1342
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
10.2
522
3899
M01AX17
ATC
nimesulide; oral
1.4
10.2
560
4236
R03AC02
ATC
salbutamol; inhalant
1.3
10.1
1380
11943
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
10.0
1975
17915
ZZH20
NOMESCO Finland
Graft of patients own bone
6.1
10.0
26
43
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
40.2
10.0
12
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
9.9
569
4329
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
9.8
1038
8666
J01FA06
ATC
roxithromycin; oral
1.3
9.8
1017
8474
A02BC01
ATC
omeprazole; systemic
1.4
9.7
633
4920
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
1.8
9.7
153
849
M02AA07
ATC
piroxicam; topical
1.3
9.7
857
6981
L15
ICPC
Knee symptom/complaint
1.4
9.5
478
3550
A02BC03
ATC
lansoprazole; oral
1.3
9.5
690
5453
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
9.5
525
3967
J01CA04
ATC
amoxicillin; systemic
1.3
9.4
2290
21251
S62.6
ICD-10 Finland
Fracture of other finger
2.0
9.4
117
596
NHR99
NOMESCO Finland
Other operation for tumour of ankle or foot
30.1
9.4
12
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
9.4
412
2982
L13
ICPC
Hip symptom/complaint
1.5
9.4
331
2295
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.8
9.2
142
786
UJF32
NOMESCO Finland
Coloscopy
1.4
9.1
578
4471
D21.2
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of lower limb, including hip
6.3
9.1
23
37
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
9.0
1057
8925
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
2.5
9.0
70
289
ND1BG
NOMESCO Finland
Wrist and hand MRI examination with high intensity magnet
3.2
9.0
44
137
M89.3
ICD-10 Finland
Hypertrophy of bone
18.6
8.9
13
7
M12.2
ICD-10 Finland
Villonodular synovitis (pigmented)
18.6
8.9
13
7
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
8.9
1561
13848
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.8
8.9
137
759
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
8.8
696
5564
B01AB05
ATC
enoxaparin; parenteral
1.3
8.7
678
5407
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.6
8.7
220
1409
R93.7
ICD-10 Finland
Abnormal findings on diagnostic imaging of other parts of musculoskeletal system
14.1
8.7
14
10
N02AA05
ATC
oxycodone; systemic
1.5
8.7
277
1876
M01AC06
ATC
meloxicam; systemic, rectal
1.3
8.7
886
7340
H02AB06
ATC
prednisolone; systemic
1.3
8.6
1143
9785
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.6
8.6
247
1628
M85.0
ICD-10 Finland
Fibrous dysplasia (monostotic)
16.3
8.5
13
8
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.1
8.5
92
443
E0000UV
ATC
NA
1.3
8.5
996
8397
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
8.5
610
4802
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
8.4
393
2882
D16.9
ICD-10 Finland
Benign neoplasm: Bone and articular cartilage, unspecified
+∞
8.3
8
*
D16.4
ICD-10 Finland
Benign neoplasm: Bones of skull and face
+∞
8.3
8
*
XKD00
NOMESCO Finland
Uroflowmetry
1.5
8.3
293
2031
ND2CG
NOMESCO Finland
Extensive MRI of hand
8.5
8.3
17
20
R53
ICD-10 Finland
Malaise and fatigue
1.4
8.2
465
3525
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
8.2
1188
10268
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
14.5
8.2
13
9
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
7.5
8.1
18
24
M16.1
ICD-10 Finland
Other primary coxarthrosis
1.6
8.1
217
1412
NDR99
NOMESCO Finland
Other operation for tumour of wrist or hand
33.4
8.1
10
*
GAE06
NOMESCO Finland
Excision of lesion of chest wall
11.7
8.1
14
12
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
1.8
8.0
139
800
TAKUU
NOMESCO Finland
NA
3.8
8.0
32
85
NHR30
NOMESCO Finland
Complete excision of soft tissue tumour of ankle or foot
22.1
8.0
11
5
J02AC01
ATC
fluconazole; systemic
1.3
8.0
1025
8722
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.5
8.0
238
1589
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
7.9
473
3613
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
7.9
388
2865
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
7.9
243
1636
ZZH31
NOMESCO Finland
Bone allograft, small pieces
4.5
7.9
26
58
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
2.5
7.8
58
234
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.3
7.8
633
5067
M48.0
ICD-10 Finland
Spinal stenosis
1.5
7.8
239
1604
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.8
7.7
129
732
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.5
7.7
252
1717
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.6
7.7
219
1441
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.7
7.7
164
1005
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
2.8
7.7
47
171
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
7.7
754
6196
K02.1
ICD-10 Finland
Caries of dentine
1.2
7.6
1553
13916
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.6
7.5
172
1075
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
7.5
663
5369
G44.2
ICD-10 Finland
Tension-type headache
1.4
7.5
319
2293
ND3CG
NOMESCO Finland
Extensive MRI of fingers
10.0
7.5
14
14
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
7.5
259
1784
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
2.7
7.5
49
186
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.7
7.4
141
836
NGR99
NOMESCO Finland
Other operation for tumour of knee or lower leg
80.3
7.4
8
*
C40.21
ICD-10 Finland
Osteosarcoma of the long bones of the lower extremity
80.3
7.4
8
*
C40.29
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity other or unspecified histology
80.3
7.4
8
*
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.7
7.4
142
842
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
1.7
7.3
152
926
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
7.3
983
8391
D16.91
ICD-10 Finland
Benign tumor in unspecified localization in bone with urpsrung in teeth
+∞
7.3
7
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
2.2
7.3
72
337
9166
FHL
Bone graft to promote ossification
9.4
7.3
14
15
R06AE07
ATC
cetirizine; oral
1.2
7.3
1138
9884
Q78.1
ICD-10 Finland
Polyostotic fibrous dysplasia
30.1
7.1
9
*
NEA20
NOMESCO Finland
Exploration of soft tissue of pelvis,v
20.1
7.1
10
5
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
7.0
239
1641
A02BA02
ATC
ranitidine; systemic
1.4
7.0
425
3256
L17
ICPC
Foot/toe symptom/complaint
1.3
7.0
562
4492
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.4
6.9
295
2120
WX002
NOMESCO Finland
Sedation and analgesia
1.4
6.9
434
3337
L16
ICPC
Ankle symptom/complaint
1.5
6.9
235
1616
R06.0
ICD-10 Finland
Dyspnoea
1.3
6.9
531
4213
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.5
6.9
246
1706
L12
ICPC
Hand/finger symptom/complaint
1.4
6.9
325
2385
J20
ICD-10 Finland
Acute bronchitis
1.5
6.9
214
1446
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.6
6.8
163
1028
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.1
6.8
71
341
6202X
ICD-9 Finland
Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Other and unspecified ovarian cyst
3.0
6.8
36
121
C40.2
ICD-10 Finland
Malignant neoplasm: Long bones of lower limb
40.1
6.8
8
*
9105
FHL
Homogeneous or heterogeneous bone graft, e.g., joint graft
40.1
6.8
8
*
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
6.7
978
8405
EBB10
NOMESCO Finland
Insertion of dental implant
3.0
6.7
36
122
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
6.6
186
1225
M85.8
ICD-10 Finland
Other specified disorders of bone density and structure
5.5
6.6
18
33
NCR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of elbow or forearm
12.3
6.6
11
9
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.7
6.5
124
737
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
6.5
651
5345
NE1CM
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with 3 Tesla magnet
10.0
6.5
12
12
WZA90
NOMESCO Finland
Other doctors statement
1.3
6.5
567
4576
H02AB04
ATC
methylprednisolone; systemic
1.4
6.5
329
2441
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
6.5
665
5479
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.9
6.5
94
514
-
ICD-10 Finland
NA
2.3
6.4
55
240
M79.1
ICD-10 Finland
Myalgia
1.4
6.4
300
2196
J01MA02
ATC
ciprofloxacin; systemic
1.2
6.4
898
7679
R50.9
ICD-10 Finland
Fever, unspecified
1.4
6.4
312
2304
F45.8
ICD-10 Finland
Other somatoform disorders
1.6
6.4
174
1136
SPAT1312
SPAT
General health counselling
1.3
6.4
792
6679
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.2
6.4
60
274
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.8
6.4
110
635
NFU20
NOMESCO Finland
Removal of internal fixation device from femur
3.9
6.4
24
62
N06AA09
ATC
amitriptyline; systemic
1.5
6.3
219
1514
M01AH03
ATC
valdecoxib; oral
1.6
6.3
145
910
EDB00
NOMESCO Finland
Partial excision of mandible
11.0
6.3
11
10
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
2.0
6.3
78
402
ND1CM
NOMESCO Finland
Wrist and hand extensive MRI examination with 3 Tesla magnet
9.3
6.3
12
13
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
18.0
6.3
9
5
EEB00
NOMESCO Finland
Partial excision of maxilla
18.0
6.3
9
5
D07AC01
ATC
betamethasone; topical
1.2
6.3
797
6736
WX203
NOMESCO Finland
Infraclavicular plexus blockade
2.2
6.3
59
270
C40.02
ICD-10 Finland
Chondrosarcoma of the scapula and long bones of the upper extremity
+∞
6.2
6
*
4339
FHL
Other measure in this category
+∞
6.2
6
*
2132A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Vertebral column, excluding sacrum and coccyx
+∞
6.2
6
*
4332
FHL
Lower jaw resection or tumor removal
+∞
6.2
6
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
6.2
720
6017
1220
FHL
Arthroscopy
1.8
6.2
92
505
EDC45
NOMESCO Finland
Reconstruction of mandible using bone graft
26.7
6.2
8
*
9180/3-C40.2
ICD-O-3
Osteosarcoma, NOS, of long bones of lower limb and associated joints
26.7
6.2
8
*
WX290
NOMESCO Finland
Other blockade of nerve
1.2
6.2
1186
10475
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
1.6
6.1
151
964
J02AC02
ATC
itraconazole; systemic
1.3
6.1
406
3154
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
6.1
327
2453
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
6.1
345
2612
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.6
6.0
147
937
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.3
6.0
530
4280
NAR20
NOMESCO Finland
Complete excision of soft tissue tumour of spine, unspecified
6.7
6.0
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
1438
11171
1.50
27.75
2.1
2.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2365
20461
1.51
25.70
4.5
4.0
mm/h
10.2
11.0
2.69
2203
19068
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2353
20879
1.41
18.20
7.6
7.3
u/l
77.2
76.7
0.19
2226
19743
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
662
4774
1.48
16.86
1.3
1.3
u/ml
9.0
10.0
0.18
270
1944
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1532
12834
1.35
16.08
4.0
3.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1807
15521
1.35
16.07
4.5
4.7
mmol/l
6.5
6.6
2.12
1696
14435
(3031040) Bacteria [#/volume] in Urine by Automated count
2034
17792
1.35
16.02
4.6
4.2
e6/l
2899.6
1680.0
0.18
17
237
(3037522) Nuclear Ab [Titer] in Serum
559
3975
1.49
15.12
1.4
1.4
titre
522.7
515.8
0.03
105
798
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
679
5048
1.43
14.49
1.4
1.3
iu/ml
27.2
30.3
0.17
210
1571
(3044640) Blood type and Crossmatch panel - Blood
1062
8520
1.36
14.35
2.3
2.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
2116
18832
1.32
13.63
4.5
4.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1336
11166
1.32
13.45
4.6
4.8
g/l
36.1
36.0
0.30
1223
10433
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3005
28327
1.51
13.30
14.2
12.8
mg/l
21.5
22.5
0.95
2443
22108
(3026493) Urate [Moles/volume] in Serum or Plasma
888
7007
1.36
13.12
2.5
2.5
umol/l
1641.9
4458.3
2.42
778
6166
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
444
3109
1.49
12.83
7.2
6.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
827
6489
1.36
12.59
2.3
2.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1122
9232
1.32
12.34
5.6
6.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1489
12733
1.30
12.34
6.5
6.6
mmol/l
1.2
1.2
0.03
1239
10778
(3019550) Sodium [Moles/volume] in Serum or Plasma
3010
28471
1.48
12.19
15.4
14.2
mmol/l
139.7
139.7
1.20
2934
27776
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1358
11510
1.30
11.90
5.8
6.0
mmol/l
1.2
1.2
0.06
1215
10485
(3032080) INR in Blood by Coagulation assay
1204
10045
1.31
11.86
6.9
8.3
inr
1.2
1.2
0.55
318
3019
(3002256) Pathology report gross observation
478
3447
1.45
11.84
1.3
1.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
3014
28561
1.47
11.63
15.6
14.3
mmol/l
4.0
4.0
0.31
2929
27817
(3009261) Glucose [Presence] in Urine by Test strip
1562
13599
1.27
10.69
3.7
3.5
estimate
0.0
0.0
1.57
304
2473
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1578
13776
1.27
10.48
5.9
6.1
umol/l
11.3
11.1
0.15
1484
13087
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
941
7695
1.31
10.47
2.1
2.1
u/l
214.2
226.7
0.11
898
7259
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2385
21905
1.29
10.44
4.2
4.0
pmol/l
14.7
14.6
0.08
2207
20160
(3035350) Ketones [Presence] in Urine by Test strip
1542
13442
1.27
10.31
3.7
3.4
estimate
0.0
0.0
0.50
307
2496
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1011
8367
1.30
10.24
2.7
2.5
u/l
60.6
57.2
0.31
920
7757
(3021601) Nitrite [Presence] in Urine by Test strip
1543
13468
1.27
10.14
4.9
4.7
estimate
0.0
0.0
0.50
314
2564
(40761511) CBC panel - Blood by Automated count
3096
29700
1.45
9.11
13.6
11.8
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
182
1133
1.64
8.84
1.3
1.3
u/ml
0.6
0.9
0.31
12
98
(3013115) Eosinophils [#/volume] in Blood
1633
14492
1.24
8.81
6.1
6.1
e9/l
0.2
0.2
0.09
1453
12832
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1123
9586
1.26
8.50
3.3
3.3
ng/l
32.1
48.3
1.11
701
5936
(3029937) Albumin [Presence] in Urine by Test strip
869
7203
1.28
8.40
4.3
3.8
estimate
0.0
0.0
1.28
301
2488
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1214
10473
1.25
8.32
4.0
3.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
490
3761
1.35
8.28
1.3
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2740
25881
1.30
8.17
5.0
4.7
mu/l
2.7
2.0
0.32
2548
24023
(3001604) Monocytes [#/volume] in Blood
1568
13947
1.23
7.98
6.0
5.9
e9/l
0.6
0.6
0.22
1375
12153
(3006315) Basophils [#/volume] in Blood
1572
13991
1.23
7.94
6.0
5.9
e9/l
0.0
0.0
0.08
1375
12181
(3042936) Bacteria identified in Isolate by Culture
483
3723
1.35
7.92
2.1
2.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1613
14408
1.23
7.83
6.0
5.9
e9/l
2.0
2.0
0.12
1439
12799
(3013512) EKG study
863
7204
1.26
7.78
3.8
3.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1290
11269
1.23
7.72
2.4
2.2
nmol/l
77.5
75.7
1.25
1177
10302
(3015377) Calcium [Moles/volume] in Serum or Plasma
1026
8745
1.25
7.70
3.0
3.3
mmol/l
2.4
2.4
0.24
900
7764
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
118
680
1.76
7.66
1.4
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
85
446
1.93
7.44
1.5
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
790
6563
1.27
7.36
1.3
1.3
u/ml
1.2
1.6
0.53
215
1789
(3007853) Bacteria identified in Skin by Aerobe culture
415
3160
1.36
7.36
1.7
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1775
16096
1.21
7.14
8.4
9.0
e9/l
4.0
4.0
0.10
1565
14139
(3008898) HLA-B27 [Presence]
177
1157
1.56
7.07
1.1
1.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
814
6815
1.26
7.06
3.6
3.9
%
92.4
92.4
0.02
792
6638
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
408
3132
1.34
6.85
4.0
4.1
%
32.3
31.9
0.28
282
2189
(40768443) Skin Pathology biopsy report
170
1122
1.54
6.53
1.3
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
289
2128
1.39
6.31
2.6
2.7
g/l
9.7
10.4
2.83
261
1956
(3022096) Basophils/100 leukocytes in Blood
1415
12658
1.20
6.27
6.2
6.1
%
0.7
0.7
0.08
1310
11863
(3000475) Leukocytes [#/volume] in Synovial fluid
104
614
1.72
6.27
1.5
1.7
e6/l
14189.9
12687.4
0.13
80
454
(3041096) Erythrocytes [Presence] in Urine by Automated
880
7517
1.23
6.25
3.3
3.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
1463
13136
1.20
6.20
6.5
6.3
%
8.5
8.5
0.06
1365
12364
(3006504) Eosinophils/100 leukocytes in Blood
1454
13049
1.20
6.19
6.2
6.1
%
2.9
2.8
0.31
1353
12203
(3003458) Phosphate [Moles/volume] in Serum or Plasma
422
3310
1.31
6.09
5.2
6.1
mmol/l
1.0
1.0
0.24
402
3090
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
61
307
2.00
6.08
1.5
1.7
%
59.4
58.1
0.08
37
194
(3026008) Bacteria identified in Urine by Culture
877
7534
1.22
5.83
3.0
2.9
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1484
13393
1.19
5.82
6.1
5.9
%
56.4
56.8
0.62
1388
12596
(3020630) Protein [Mass/volume] in Serum or Plasma
262
1936
1.38
5.62
2.6
2.6
g/l
67.2
66.7
0.53
240
1779
(3002030) Lymphocytes/100 leukocytes in Blood
1497
13564
1.18
5.51
6.3
6.1
%
29.0
28.6
0.75
1398
12714
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2802
26851
1.24
5.49
4.5
4.2
mmol/l
5.8
5.9
0.70
2581
24780
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1158
10285
1.19
5.31
1.9
1.9
pmol/l
100.6
96.5
1.82
613
5429
(40761535) Cells panel - Urine sediment
279
2102
1.36
5.31
3.8
3.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
760
6499
1.22
5.22
2.7
2.9
ng/l
1011.0
1175.9
0.63
634
5464
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1392
12588
1.18
5.12
3.0
2.8
ug/l
105.0
113.8
1.08
1307
11756
(3007164) IgA [Mass/volume] in Serum or Plasma
678
5749
1.22
5.05
1.6
1.5
g/l
2.2
2.3
1.83
432
3624
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
91
553
1.66
5.00
1.4
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
280
2133
1.34
4.97
2.3
2.5
ml/min/173m2
70.8
70.7
0.02
131
821
(3048689) Calprotectin [Mass/mass] in Stool
451
3666
1.27
4.92
2.5
2.4
ug/g
111.8
125.0
0.53
349
2940
(3024731) MCV [Entitic volume]
3250
31833
1.43
4.86
21.0
18.6
fl
90.6
90.6
0.29
3214
31454
(3035941) MCH [Entitic mass]
3250
31834
1.43
4.84
21.0
18.6
pg
30.2
30.2
0.25
3214
31452
(3026361) Erythrocytes [#/volume] in Blood
3250
31837
1.43
4.81
21.1
18.7
e12/l
4.5
4.5
0.04
3178
31048
(3000963) Hemoglobin [Mass/volume] in Blood
3251
31849
1.43
4.81
21.2
18.8
g/l
136.3
136.4
0.12
3214
31461
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
81
483
1.69
4.79
2.5
3.6
u/ml
355.7
881.1
0.46
72
456
(3019225) pH of Specimen
318
2481
1.31
4.78
3.5
3.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
644
5468
1.22
4.71
2.4
2.5
e6/l
6.1
6.2
0.07
560
4803
(3010813) Leukocytes [#/volume] in Blood
3250
31846
1.43
4.71
21.1
18.7
e9/l
6.7
6.7
0.09
3179
31059
(3018418) pH of Serum or Plasma
865
7554
1.19
4.70
4.0
3.9
ph
7.4
7.4
0.72
179
1469
(40760892) CBC W Ordered Manual Differential panel - Blood
758
6554
1.20
4.58
4.8
4.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
3246
31813
1.41
4.56
21.2
18.7
e9/l
256.3
255.3
0.42
3182
31094
(3012095) Magnesium [Moles/volume] in Serum or Plasma
502
4170
1.24
4.53
3.5
3.6
mmol/l
0.8
0.8
0.68
473
3925
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2085
19599
1.16
4.41
3.4
3.0
u/l
45.0
45.2
0.06
1944
18502
(3028026) IgM [Mass/volume] in Serum or Plasma
221
1659
1.36
4.35
2.0
1.8
g/l
1.4
1.4
0.04
200
1537
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
574
4860
1.22
4.30
3.3
3.5
ng/l
598.1
472.9
0.21
386
3472
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
53
289
1.85
4.28
2.7
3.1
nmol/l
2.2
24.4
0.61
47
281
(36304419) Bacteria [Presence] in Urine
813
7113
1.19
4.28
3.0
3.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
697
6022
1.20
4.22
1.6
1.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
332
2650
1.28
4.22
2.4
2.1
nmol/l
344.3
370.4
1.75
309
2433
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2742
26395
1.20
4.18
12.4
11.6
ml/min/173m2
86.0
85.3
0.91
2307
21738
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
339
2720
1.27
4.13
4.2
4.2
u/l
241.6
244.2
0.09
322
2578
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
40
201
2.00
4.11
2.1
2.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2628
25213
1.18
4.11
5.6
5.2
mmol/mol
38.8
39.2
1.35
2449
23592
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
120
817
1.49
4.11
1.3
1.2
u/ml
2.2
42.5
—
5
51
(36660697) Celiac disease serology panel - Serum
297
2348
1.29
4.07
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2130
20113
1.16
4.06
3.3
3.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
478
3999
1.23
4.03
1.8
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
209
1583
1.34
3.91
1.1
1.0
—
—
—
0
0
(3026782) Osmolality of Urine
589
5054
1.20
3.83
2.8
2.7
mosm/kgh2o
561.9
549.9
0.60
494
4307
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
237
1834
1.31
3.83
2.8
3.3
pmol/l
4.5
4.5
0.13
213
1650
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
130
914
1.44
3.80
1.8
1.9
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
45
243
1.86
3.79
1.4
1.5
%
38.5
33.6
0.38
31
148
(3030467) Casts [#/volume] in Urine by Automated count
815
7200
1.17
3.77
3.0
3.0
e6/l
0.4
0.4
0.11
631
5385
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
533
4537
1.21
3.77
2.7
2.9
mmol/l
2.4
2.4
0.65
464
3977
(3023323) Follitropin [Units/volume] in Serum or Plasma
214
1640
1.33
3.71
1.5
1.3
iu/l
25.3
27.3
0.39
189
1402
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
166
1227
1.37
3.65
1.9
1.9
u/l
39.5
38.9
0.15
149
1103
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
110
758
1.47
3.59
1.3
1.2
u/ml
8.2
8.1
0.00
14
124
(3005322) IgE [Units/volume] in Serum or Plasma
249
1959
1.29
3.57
1.3
1.3
u/ml
248.9
211.4
0.21
236
1817
(3000570) Elastase.pancreatic [Mass/mass] in Stool
111
767
1.46
3.57
1.4
1.4
ug/g
248.7
294.5
1.34
55
427
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
65
399
1.64
3.54
1.8
1.3
ug/l
5.4
3.9
0.32
56
362
(3000494) Fungus identified in Specimen by Culture
390
3239
1.23
3.53
1.4
1.5
—
—
—
0
0
(4010399)
240
1883
1.30
3.52
1.4
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
623
5414
1.18
3.50
1.6
1.6
pmol/l
442.8
36114565.0
5.04
514
4591
(3023368) Bacteria identified in Blood by Culture
754
6657
1.17
3.49
4.2
4.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
835
7438
1.16
3.45
4.8
4.4
ug/l
1.9
2.3
1.57
773
6725
(3004588) Protein electrophoresis panel - Serum or Plasma
207
1597
1.32
3.44
2.2
2.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
55
327
1.69
3.39
1.2
1.3
nmol/l
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
249
1974
1.28
3.38
2.9
2.8
e9/l
3.9
4.1
0.80
191
1601
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
709
6248
1.17
3.35
1.8
1.7
mg/l
1.0
1.1
0.12
545
4686
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
12
37
3.25
3.34
1.0
1.0
u/ml
0.1
2.1
—
7
26
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
107
746
1.45
3.31
1.3
1.2
u/ml
36.2
3.1
—
9
79
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
303
2466
1.25
3.31
2.5
2.3
g/l
0.2
0.2
1.18
287
2308
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
61
376
1.63
3.29
1.2
1.3
nmol/l
0.2
0.3
—
5
22
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2906
28255
1.19
3.28
4.7
4.5
mmol/l
2.8
2.8
0.84
2694
26386
(3013005) Retinol [Moles/volume] in Serum or Plasma
26
122
2.14
3.25
1.5
1.8
umol/l
2.0
2.0
0.06
26
116
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
335
2763
1.24
3.25
1.7
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
744
6599
1.16
3.23
2.3
2.1
mg/l
2.8
2.9
0.23
645
5666
(3021387) Prolactin [Units/volume] in Serum or Plasma
160
1202
1.35
3.21
1.6
1.6
mu/l
314.9
299.2
0.19
149
1085
(3019150) Specific gravity of Urine by Refractometry
669
5888
1.17
3.21
4.2
3.8
kg/l
1.0
1.0
0.25
100
829
(3021960) Folate [Moles/volume] in Serum or Plasma
646
5672
1.17
3.19
1.5
1.5
nmol/l
21.0
20.5
0.36
556
4912
(3009508) Creatinine [Moles/volume] in Urine
896
8076
1.15
3.11
3.4
3.3
mmol/l
8.0
7.8
0.33
760
6885
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
330
2733
1.23
3.09
1.7
1.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
874
7868
1.15
3.09
3.1
3.1
e6/l
55.3
96.8
0.85
673
6006
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
234
1864
1.27
3.08
1.3
1.3
au/ml
28.3
48.9
—
6
79
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
38
209
1.83
3.08
2.1
2.1
%
14.8
13.1
0.32
20
96
(3044889) 12 lead EKG panel
1998
18964
1.13
3.05
3.8
3.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
18
74
2.44
3.04
3.3
2.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2866
27874
1.18
3.02
4.4
4.1
mmol/l
4.7
4.7
1.34
2662
26200
(3011397) Hemoglobin [Presence] in Urine by Test strip
700
6213
1.16
3.00
3.9
3.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
80
538
1.50
3.00
1.1
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
353
2954
1.22
2.99
24.0
21.8
inr
1.2
1.3
0.43
51
438
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
14
51
2.75
2.98
1.9
1.4
ug/l
0.6
0.3
—
9
35
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
295
2425
1.24
2.97
3.7
4.1
ug/l
35.2
20.8
0.35
232
1938
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
56
348
1.62
2.96
1.2
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
432
3693
1.19
2.93
2.1
2.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
249
2013
1.26
2.91
2.2
2.4
ug/l
6.4
7.4
0.39
216
1803
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1025
9360
1.14
2.90
3.5
3.2
u/l
32.3
34.3
0.40
981
8900
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
452
3887
1.19
2.87
1.7
1.8
%
1.5
1.4
0.27
397
3468
(3017181) Myelocytes/100 leukocytes in Blood
278
2280
1.24
2.87
4.4
4.2
%
1.0
0.9
0.24
73
618
(3044941) Cell count panel - Synovial fluid
63
407
1.56
2.85
1.4
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
254
2064
1.25
2.85
4.0
3.7
mmol/l
1.2
1.2
0.48
218
1804
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
230
1848
1.26
2.84
3.2
3.9
ng/l
72.7
82.9
1.42
206
1632
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2755
26743
1.16
2.84
3.9
3.7
mmol/l
1.3
1.3
1.77
2550
24888
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
35
193
1.82
2.84
1.5
2.0
mg/l
3.2
4.0
0.96
35
184
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
370
3130
1.20
2.81
2.6
2.8
umol/l
9.5
7.5
0.66
318
2722
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
167
1291
1.31
2.79
2.4
2.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
251
2043
1.25
2.78
4.5
4.3
%
0.1
0.4
0.74
61
474
(3002523) Influenza virus A Ag [Presence] in Specimen
79
540
1.47
2.76
1.1
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
255
2081
1.24
2.76
4.3
4.0
%
0.5
0.6
0.18
60
446
(3010144) Erythrocytes [#/volume] in Synovial fluid
43
255
1.70
2.74
1.3
1.4
e6/l
116401.5
86941.6
0.14
25
178
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2845
27701
1.16
2.73
4.3
4.1
mmol/l
1.5
1.5
0.18
2639
25904
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3076
30147
1.20
2.71
10.9
9.7
u/l
27.4
26.9
0.67
2982
29247
(3019309) Folate [Moles/volume] in Red Blood Cells
499
4348
1.17
2.71
1.8
1.7
nmol/l
1202.5
1172.3
0.31
381
3349
(3017446) Testosterone [Moles/volume] in Serum or Plasma
256
2096
1.24
2.70
2.1
2.3
nmol/l
12.7
12.9
0.17
232
1877
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
72
486
1.49
2.69
1.8
1.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
45
272
1.66
2.68
2.2
2.5
e9/l
1.2
1.2
0.08
26
156
(3007566) Smooth muscle Ab [Titer] in Serum
107
779
1.39
2.67
1.2
1.3
titre
109.0
87.1
—
10
69
(1616796) Gas panel - Central venous blood
81
562
1.45
2.64
4.0
3.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
262
2156
1.23
2.64
1.2
1.2
iu/ml
144.4
155.9
0.16
96
810
(3018095) Leukocytes [#/volume] in Urine
1021
9369
1.13
2.64
3.6
3.6
e6/l
58.4
90.9
1.12
728
6512
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
143
1094
1.32
2.60
1.5
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
84
589
1.44
2.60
4.5
4.3
mmol/l
2.1
2.5
0.81
56
387
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
84
589
1.44
2.60
1.3
1.2
u/ml
7.7
3.6
—
8
42
(3022145) Colonoscopy Study observation
355
3019
1.20
2.57
1.4
1.3
—
—
—
0
0
(3039000) Anion gap in Blood
80
558
1.44
2.55
6.0
8.2
mmol/l
10.9
11.4
0.75
70
499
(3004616) Nuclear Ab [Presence] in Serum
53
339
1.57
2.54
1.4
1.3
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
80
559
1.44
2.53
6.0
8.2
mmol/l
104.7
105.3
0.67
70
500
(3018677) aPTT in Platelet poor plasma by Coagulation assay
448
3894
1.17
2.52
1.9
2.2
s
29.6
29.7
0.05
429
3770
(3021440) Promyelocytes/100 leukocytes in Blood
262
2170
1.22
2.49
4.5
4.3
%
0.2
0.1
0.54
67
566
(3017143) Hepatitis C virus Ab [Presence] in Serum
418
3616
1.18
2.49
1.7
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
169
1334
1.28
2.45
8.6
11.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
496
4359
1.16
2.42
2.7
2.6
e6/l
1.3
1.1
0.15
283
2432
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
470
4114
1.17
2.42
2.2
2.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
246
2032
1.23
2.41
2.4
2.4
au/ml
17.3
22.4
0.49
14
134
(3022948) Iron [Moles/volume] in Serum or Plasma
458
4003
1.17
2.40
2.2
2.4
umol/l
14.6
13.7
1.69
426
3725
(40761536) Microorganisms panel - Urine sediment
283
2372
1.21
2.40
4.1
3.8
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
5
8
6.26
2.37
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
33
191
1.73
2.33
1.0
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
106
790
1.35
2.33
5.6
6.9
mmol/l
1.3
1.3
0.10
90
685
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
10
35
2.86
2.30
1.7
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
61
414
1.48
2.27
1.5
1.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
831
7596
1.12
2.25
3.9
4.0
mg/mmol
5.6
8.8
2.05
528
4854
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
21
106
1.99
2.25
2.3
2.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
77
548
1.41
2.24
2.2
2.3
g/l
130.6
130.5
0.00
56
399
(3004789) Transferrin [Mass/volume] in Serum or Plasma
421
3678
1.16
2.23
2.3
2.4
g/l
2.4
2.4
1.22
395
3429
(3021589) Normoblasts [#/volume] in Blood
1322
12403
1.11
2.22
9.6
9.0
e9/l
0.0
0.0
1.28
1086
10139
(3039443) Prostate specific Ag panel - Serum or Plasma
76
541
1.41
2.21
1.5
1.7
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
47
304
1.55
2.19
2.1
1.4
g/l
0.3
0.4
1.42
25
211
(3028192) IgG subclass 2 [Mass/volume] in Serum
47
304
1.55
2.19
2.1
1.4
g/l
2.7
2.9
0.52
24
213
(3034274) Bile acid [Moles/volume] in Serum --fasting
58
393
1.48
2.18
2.2
2.1
umol/l
5.5
6.0
0.19
34
285
(3009214) Lutropin [Units/volume] in Serum or Plasma
120
922
1.31
2.17
1.4
1.4
u/l
10.2
9.7
0.14
102
761
(4035726)
268
2259
1.20
2.17
1.4
1.4
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
30
173
1.74
2.16
1.6
1.4
u/l
4.9
7.5
1.53
25
147
(3003327) Ova and parasites identified in Stool by Light microscopy
126
975
1.30
2.16
1.8
1.7
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
47
305
1.55
2.16
2.1
1.4
g/l
5.7
6.6
1.36
25
213
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
26
144
1.81
2.14
1.6
1.5
u/l
11.5
13.4
0.80
26
137
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
39
243
1.61
2.13
1.2
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
23
123
1.88
2.11
1.2
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
667
6047
1.13
2.07
1.9
1.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
792
7254
1.12
2.06
3.2
3.3
mg/l
323.2
362.5
0.08
498
4602
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
33
199
1.66
2.05
1.2
1.2
—
3.8
—
0
11
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
389
3404
1.16
2.03
2.4
2.5
%
25.2
23.5
1.22
327
2938
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
72
517
1.40
2.02
1.5
1.4
nmol/l
0.3
0.4
0.19
58
406
(3020191) Ethanol [Moles/volume] in Serum or Plasma
37
232
1.60
1.99
1.3
1.5
promille
1.4
1.2
0.27
27
184
(3024891) Influenza virus A+B Ag [Presence] in Specimen
104
795
1.32
1.98
1.1
1.2
—
—
—
0
0
(3010421) pH of Blood
93
700
1.34
1.97
4.4
4.1
ph
7.4
7.4
0.13
80
582
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
216
1803
1.21
1.96
1.6
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
84
623
1.36
1.95
1.3
1.2
u/ml
61.2
40.5
—
7
63
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
19
98
1.94
1.95
1.1
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
19
98
1.94
1.95
3.6
4.8
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
8
27
2.97
1.93
1.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
32
195
1.65
1.93
1.1
1.1
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
13
58
2.25
1.90
1.1
1.1
u/ml
0.0
5.8
—
8
44
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
23
128
1.80
1.89
1.3
3.0
umol/l
213.1
171.1
—
9
73
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
23
128
1.80
1.89
1.1
1.1
iu/ml
397.6
192.8
0.38
23
128
(4062490)
46
308
1.50
1.87
2.2
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
62
441
1.41
1.86
1.0
1.1
u/ml
2.1
5.4
2.29
28
177
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
653
5950
1.12
1.86
4.2
3.9
%
20.7
21.3
0.40
306
2658
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
455
4054
1.14
1.86
2.8
2.8
e6/l
3.1
2.7
0.40
246
2138
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
13
59
2.21
1.84
1.0
1.1
%
98.3
91.5
0.53
13
59
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
13
59
2.21
1.84
1.0
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
68
493
1.39
1.83
2.4
1.7
g/l
1.1
0.8
0.92
43
380
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
5
12
4.17
1.82
1.0
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
65
469
1.39
1.81
1.8
1.7
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
97
747
1.31
1.78
4.3
3.9
mg/l
1.4
1.5
0.43
91
700
(3025941) Bacteria identified in Stool by Culture
199
1668
1.20
1.76
1.3
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
275
2372
1.17
1.76
1.4
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
17
88
1.94
1.74
1.4
1.4
ug/l
9.3
8.6
0.19
17
88
(21491868) Cryoglobulin [Mass/volume] in Serum
20
110
1.82
1.72
1.1
1.2
—
0.3
—
0
10
(3042111) Morphology [Interpretation] in Bone marrow Narrative
57
406
1.41
1.72
1.6
1.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
117
929
1.27
1.71
1.9
1.6
titre
136.7
220.0
—
6
31
(3036670) Protein [Mass/volume] in Synovial fluid
15
75
2.00
1.69
1.0
1.2
g/l
43.6
37.9
—
5
44
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
100
780
1.29
1.68
2.5
2.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
96
745
1.30
1.68
1.7
1.7
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
31
195
1.60
1.68
2.4
2.7
e6/l
463.9
572.1
0.59
19
160
(3000492) Spirometry study
327
2870
1.15
1.68
1.4
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
222
1890
1.19
1.67
2.5
2.8
ng/l
184.4
176.3
0.07
199
1704
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
162
1339
1.22
1.66
2.4
2.2
u/l
4533.5
4590.6
0.01
53
518
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
108
853
1.27
1.66
1.9
2.4
ug/l
545.4
436.8
0.20
96
798
(3002173) Hemoglobin [Mass/volume] in Arterial blood
271
2348
1.17
1.65
8.2
9.0
g/l
122.2
123.2
0.34
262
2260
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
29
181
1.61
1.63
1.3
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
757
7011
1.10
1.59
6.4
6.7
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
15
77
1.95
1.59
1.3
1.5
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
20
3.00
1.58
1.7
1.1
—
—
—
0
0
(4038314)
6
20
3.00
1.58
1.2
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
28
175
1.60
1.57
1.3
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
58
423
1.38
1.55
1.4
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
45
314
1.44
1.54
2.7
2.9
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
19
107
1.78
1.54
1.1
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
178
1498
1.20
1.54
2.5
3.1
u/ml
28.3
46.0
2.16
170
1446
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
85
659
1.30
1.53
2.0
1.9
pmol/l
193.4
204.8
0.45
80
622
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
112
900
1.25
1.51
1.7
1.8
nmol/l
39.7
38.9
0.13
107
874
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
13
65
2.00
1.48
3.7
3.3
ng/l
191.5
175.2
—
7
39
(3003396) Base excess in Arterial blood by calculation
319
2823
1.14
1.48
7.6
8.1
mmol/l
1.1
1.1
0.13
257
2186
(3049717) Cytology report of Urine Cyto stain
107
858
1.26
1.48
2.7
2.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
140
1157
1.22
1.47
1.8
1.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
46
326
1.42
1.47
1.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
19
109
1.75
1.46
1.3
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
10
45
2.23
1.46
1.2
2.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
114
925
1.24
1.43
1.9
1.7
g/l
1.2
1.2
0.36
104
877
(40761539) Cells [Type] in Urine sediment by Light microscopy
13
66
1.97
1.43
1.1
1.2
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
29
188
1.55
1.42
2.6
2.8
e9/l
0.2
0.2
0.03
19
160
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
29
188
1.55
1.42
1.1
1.1
iu/ml
4.9
10.2
—
8
54
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
319
2832
1.14
1.42
7.7
8.1
kpa
5.1
5.1
0.15
300
2708
(3044927) Protein electrophoresis panel - Urine
35
237
1.48
1.41
1.2
1.1
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
319
2833
1.14
1.41
7.7
8.1
kpa
12.7
12.6
0.13
300
2711
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
53
388
1.37
1.41
1.1
1.1
g/l
1.4
1.5
0.54
48
354
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
16
88
1.82
1.41
1.8
1.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
115
936
1.24
1.41
1.7
1.8
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
103
828
1.25
1.41
1.1
1.1
u/ml
0.8
4.3
—
9
117
(3024869) Neuronal Ab [Presence] in Serum
10
46
2.18
1.40
1.0
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
139
1157
1.21
1.38
1.9
1.5
u/ml
20.2
15.7
—
5
32
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
32
214
1.50
1.38
1.2
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
189
1618
1.18
1.38
4.7
5.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
55
408
1.35
1.36
1.6
1.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
43
306
1.41
1.36
1.5
2.3
mg/l
16.0
23.1
—
8
85
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
84
663
1.27
1.35
1.1
1.1
u/ml
0.6
1.4
1.30
36
273
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
108
879
1.24
1.34
1.5
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
21
128
1.64
1.33
1.2
2.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
44
316
1.40
1.33
1.5
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
35
241
1.46
1.32
3.1
2.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
55
411
1.34
1.31
1.1
1.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
6
24
2.50
1.30
1.2
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
27
177
1.53
1.28
4.9
7.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
33
226
1.46
1.28
1.3
1.3
u/ml
0.2
0.5
0.59
16
94
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
64
491
1.31
1.28
3.1
3.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
132
1103
1.20
1.28
1.6
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
170
1454
1.18
1.27
1.5
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
30
202
1.49
1.27
1.2
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
95
768
1.24
1.26
1.8
2.5
g/l
0.4
0.9
1.77
78
684
(1002224) Polysomnography panel
155
1316
1.19
1.26
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
78
616
1.27
1.26
1.5
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
103
841
1.23
1.25
1.2
1.1
—
—
—
0
0
(44813793)
31
211
1.47
1.25
1.1
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
66
511
1.30
1.24
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
66
511
1.30
1.24
1.2
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
117
969
1.21
1.24
5.2
5.9
%
2.1
1.7
0.91
107
901
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
41
296
1.39
1.22
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
30
204
1.47
1.22
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2715
26671
1.09
1.21
14.7
13.5
%
40.2
40.2
0.00
2030
20332
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
32
221
1.45
1.21
1.1
1.3
mmol/l
1.7
2.0
1.35
32
207
(3007930) Methemoglobin/Hemoglobin.total in Blood
116
964
1.21
1.20
5.3
6.0
%
0.9
0.9
0.01
106
899
(3006922) Hepatitis E virus Ab [Presence] in Serum
30
205
1.47
1.19
1.1
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
106
875
1.22
1.18
3.0
3.7
u/ml
487.1
1792.9
0.58
90
755
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
108
894
1.21
1.17
2.0
1.7
g/l
0.2
0.2
0.07
95
846
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
24
157
1.53
1.17
2.2
2.6
u/ml
621.1
1061.1
1.26
24
157
(3044242) Glucose [Moles/volume] in Arterial blood
6
127
0.47
1.16
2.2
2.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
10
50
2.00
1.16
1.5
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
33
0.00
1.16
0.0
1.2
—
1.8
—
0
33
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
28
190
1.48
1.16
1.2
1.7
—
—
—
0
0
(4146454)
36
257
1.41
1.15
2.0
2.7
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
8
39
2.05
1.15
1.1
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
66
518
1.28
1.14
3.0
2.5
%
16.6
16.5
0.12
36
258
(40760888) Immunoglobulin light chains.free panel - Serum
66
518
1.28
1.14
3.9
3.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
124
1044
1.19
1.13
1.9
2.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
76
608
1.26
1.13
1.1
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
70
555
1.27
1.12
3.4
3.7
%
56.8
57.0
0.05
70
555
(3016502) Oxygen saturation in Arterial blood
282
2528
1.13
1.12
7.9
8.6
%
96.0
95.8
0.26
270
2442
(3037556) Urate [Mass/volume] in Serum or Plasma
13
73
1.78
1.10
1.5
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
178
1549
1.16
1.10
6.8
7.5
mmol/l
24.8
24.5
0.59
168
1444
(3011288) Drugs identified in Urine by Screen method
116
974
1.20
1.10
5.4
3.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
31
2.26
1.10
1.1
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
55
424
1.30
1.10
2.8
3.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
71
566
1.26
1.10
1.0
1.1
u/ml
2.7
2.4
0.07
19
136
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
82
665
1.24
1.09
2.9
3.6
ratio
16.7
1.6
—
5
58
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
84
684
1.23
1.08
1.5
1.5
pmol/l
72.5
161.5
2.37
79
674
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
21
136
1.55
1.08
1.4
1.2
u/l
28.7
11.3
1.04
21
124
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
541
5029
1.09
1.07
1.5
1.5
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
43
321
1.34
1.07
6.4
6.8
mg/l
10.2
11.5
1.34
38
297
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
15
89
1.69
1.07
1.1
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
28
194
1.45
1.06
1.1
1.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
88
722
1.22
1.06
1.4
1.3
iu/ml
7.3
8.9
—
6
14
(3024522) Salmonella sp identified in Specimen by Organism specific culture
42
313
1.35
1.06
1.5
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
59
462
1.28
1.06
1.2
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
17
105
1.62
1.06
1.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
43
322
1.34
1.05
2.0
2.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
21
137
1.54
1.05
1.1
1.1
miu/ml
1412.7
1569.7
0.24
21
137
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
84
687
1.23
1.05
3.4
3.6
mg/l
175.9
53.9
0.41
70
561
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
28
195
1.44
1.04
1.1
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
22
2.27
1.03
4.8
2.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
22
2.27
1.03
1.0
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
177
1549
1.15
1.03
3.6
3.9
ph
7.4
7.4
0.29
29
189
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
101
844
1.20
1.02
1.4
2.4
g/l
2.9
3.1
0.97
75
663
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
171
1494
1.15
1.02
3.7
3.9
mmol/l
1.5
1.6
0.18
138
1115
(1001926) Buprenorphine [Presence] in Urine by Screen method
131
1122
1.17
1.01
3.7
2.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
27
188
1.44
1.01
1.1
1.1
u/ml
0.5
3.4
—
10
68
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
72
582
1.24
1.01
1.4
2.3
nmol/l
0.9
0.8
0.16
61
492
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
41
308
1.34
1.00
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
41
308
1.34
1.00
1.5
1.5
—
—
—
0
0
(4094501)
89
737
1.21
1.00
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
74
601
1.24
1.00
1.1
1.1
u/ml
7.7
6.2
0.27
38
318
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
106
893
1.19
0.99
1.5
2.3
g/l
3.7
3.8
0.16
72
646
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
34
248
1.37
0.99
1.5
1.9
ug/l
18.6
20.5
0.28
34
243
(3047007) Chlamydophila sp Ab [Presence] in Serum
60
476
1.27
0.99
1.3
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
471
4370
1.09
0.99
3.1
2.8
ug/l
0.7
0.7
0.06
306
2729
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
106
894
1.19
0.98
1.5
2.3
g/l
7.1
7.3
0.88
78
682
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
106
894
1.19
0.98
1.5
2.3
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
12
200
0.60
0.98
7.6
17.8
nmol/l
1111.3
1518.2
0.94
12
195
(3014133) Dog dander IgE Ab [Units/volume] in Serum
61
486
1.26
0.97
1.0
1.0
u/ml
3.9
4.2
0.05
27
176
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
2.9
—
1.1
—
0
21
(3034860) Kappa light chains.free [Mass/volume] in Serum
83
685
1.22
0.97
3.5
3.6
mg/l
34.5
63.2
1.68
69
558
(3005988) Vibrio sp identified in Specimen by Organism specific culture
41
310
1.33
0.96
1.5
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
28
199
1.41
0.95
1.4
1.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
98
824
1.19
0.95
1.6
2.4
g/l
10.1
10.1
0.04
80
708
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
12
198
0.60
0.95
6.7
13.2
nmol/l
643.2
861.9
1.02
12
191
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
41
311
1.32
0.95
1.5
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
33
242
1.37
0.94
2.5
2.5
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
6
27
2.22
0.93
1.2
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
23
158
1.46
0.93
1.6
1.4
u/ml
28.2
20.9
—
6
31
(3017817) Protein [Mass] in Urine collected for unspecified duration
32
234
1.37
0.93
4.3
2.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
210
1875
1.13
0.93
1.2
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
35
260
1.35
0.93
1.2
1.2
u/l
68.1
64.2
0.12
20
179
(3023511) Choriogonadotropin [Units/volume] in Urine
84
698
1.21
0.93
1.6
1.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
39
295
1.33
0.92
4.0
4.8
u/ml
28.5
80.5
—
9
85
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
212
1897
1.13
0.91
1.9
1.8
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
30
218
1.38
0.91
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
30
218
1.38
0.91
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
30
218
1.38
0.91
1.2
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
177
1567
1.14
0.90
3.6
3.9
kpa
5.3
5.2
0.88
162
1461
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
106
903
1.18
0.90
1.8
1.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
101
0.49
0.89
4.2
4.8
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
102
0.49
0.89
1.4
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
63
511
1.24
0.88
1.1
1.1
au/ml
12.7
13.6
—
9
35
(3006462) Nitrate [Presence] in Urine
17
111
1.53
0.87
3.2
3.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
17
111
1.53
0.87
2.0
2.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
30
220
1.37
0.87
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
30
220
1.37
0.87
1.2
1.1
—
—
—
0
0
(4198724)
21
144
1.46
0.87
1.3
1.9
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
11
64
1.72
0.86
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
11
64
1.72
0.86
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
11
64
1.72
0.86
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
11
64
1.72
0.86
1.1
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
8
44
1.82
0.85
1.9
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
109
936
1.17
0.85
2.0
2.1
ug/l
0.9
1.7
1.22
98
841
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
30
221
1.36
0.85
1.2
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
98
835
1.18
0.84
2.4
2.6
g/l
3.6
3.6
0.06
91
792
(3008401) Mugwort IgE Ab [Units/volume] in Serum
70
578
1.22
0.84
1.0
1.1
u/ml
2.0
1.4
0.23
31
250
(3048929) Epstein Barr virus Ab [Presence] in Serum
119
1032
1.16
0.83
1.3
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
18
121
1.49
0.82
1.4
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
91
773
1.18
0.82
3.2
3.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
58
708
0.82
0.80
1.4
1.5
—
—
—
0
0
(4024509)
30
224
1.34
0.79
1.7
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
58
473
1.23
0.79
1.1
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
10
58
1.73
0.79
1.2
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
10
58
1.73
0.79
1.5
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
18
257
0.70
0.77
1.1
1.4
mmol/l
14.9
12.3
—
6
64
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
47
376
1.25
0.77
1.1
1.2
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
24
174
1.38
0.76
2.3
2.7
e9/l
0.1
0.3
0.61
24
169
(3017509) Phencyclidine [Presence] in Urine
6
34
1.77
0.76
1.5
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
6
34
1.77
0.76
1.2
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
34
1.77
0.76
1.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
151
1342
1.13
0.76
3.4
2.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
36
279
1.29
0.75
1.1
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
57
691
0.82
0.75
1.4
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
239
2182
1.10
0.75
7.2
7.8
mmol/l
1.2
1.4
2.01
232
2104
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
18
124
1.45
0.75
1.4
1.4
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
5
24
2.08
0.74
1.0
1.1
u/l
29.0
1370.6
—
5
16
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
50
405
1.24
0.74
1.0
1.0
u/ml
0.0
0.4
—
9
97
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
82
699
1.18
0.73
1.5
2.3
g/l
38.9
38.0
0.71
69
613
(4034850)
77
904
0.85
0.72
10.0
8.9
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
46
567
0.81
0.72
2.7
3.7
mg/l
25.3
24.7
0.04
22
351
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
11
68
1.62
0.71
1.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
129
1141
1.14
0.71
3.9
4.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
211
1922
1.10
0.70
2.4
2.7
e9/l
68.2
71.2
0.63
159
1449
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
89
767
1.16
0.70
2.9
3.3
u/ml
0.3
0.3
0.02
53
439
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
123
1086
1.14
0.70
1.3
1.3
miu/ml
217.1
223.5
0.07
59
533
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
7
41
1.71
0.70
3.3
3.9
umol/l
31.1
42.0
—
7
32
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
286
2646
1.09
0.69
3.6
3.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
352
3286
1.08
0.68
1.6
1.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
18
127
1.42
0.67
1.2
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
18
127
1.42
0.67
2.4
3.0
ph
7.4
7.4
—
8
41
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
7
121
0.58
0.67
2.3
2.3
nmol/l
128.7
146.2
—
7
102
(3002385) Erythrocyte distribution width [Ratio]
2431
23957
1.05
0.67
16.5
15.4
%
13.6
13.6
0.22
2386
23450
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
36
285
1.27
0.66
1.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
29
223
1.30
0.66
1.1
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
58
689
0.84
0.65
1.4
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
63
532
1.19
0.64
1.6
1.5
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
30
1.67
0.61
2.0
2.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
199
0.70
0.61
1.7
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
350
3284
1.07
0.61
1.7
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
280
2605
1.08
0.61
2.5
2.4
u/l
33.0
57.7
0.75
242
2248
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
20
0.00
0.60
0.0
2.0
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
20
0.00
0.60
0.0
11.1
—
168.1
—
0
14
(4212803)
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.2
—
198.8
—
0
12
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
156
1415
1.11
0.59
1.7
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
38
308
1.24
0.59
1.5
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
24
183
1.31
0.59
1.1
2.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
282
2630
1.08
0.58
2.5
2.7
%
1.7
1.8
0.62
248
2353
(21494434) Karyotype in Bone marrow
27
210
1.29
0.58
1.1
1.2
—
—
—
0
0
(3036489) Thrombin time
120
1074
1.12
0.58
1.9
2.1
s
20.9
21.4
0.71
108
933
(3001964) Herpes simplex virus Ag [Presence] in Specimen
12
81
1.48
0.57
1.0
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
224
2073
1.09
0.57
8.5
9.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
36
1.67
0.56
1.8
2.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
31
247
1.26
0.56
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
40
484
0.82
0.56
1.1
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
43
356
1.21
0.56
1.3
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
19
141
1.35
0.56
1.4
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
11
73
1.51
0.56
1.4
1.4
—
—
—
0
0
(4211845)
17
124
1.37
0.55
3.3
3.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
55
467
1.18
0.55
1.6
1.8
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
38
1.58
0.54
1.0
2.2
—
—
—
0
0
(4133840)
12
82
1.47
0.54
1.1
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
18
239
0.75
0.54
1.7
1.6
mmol/l
7.0
7.6
0.40
11
147
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
14
99
1.42
0.54
1.5
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
14
99
1.42
0.54
1.5
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
69
599
1.16
0.54
3.0
3.9
mmol/l
25.0
24.8
0.16
60
527
(3045424) Erythrocytes [Presence] in Urine
54
460
1.18
0.53
1.4
1.6
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
39
1.54
0.53
1.2
1.3
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
24
187
1.29
0.52
1.0
1.1
u/l
0.9
1.1
—
5
94
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
63
1.43
0.52
5.4
7.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
158
1447
1.10
0.52
3.4
2.2
—
—
—
0
0
(4268621)
39
323
1.21
0.52
2.2
2.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
21
161
1.31
0.51
1.9
1.5
u/l
18.0
6.3
—
10
82
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
40
1.50
0.51
1.2
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
22
170
1.30
0.51
3.5
2.8
%
42.4
42.6
—
9
49
(3000764) Benzodiazepines [Presence] in Urine
156
1430
1.10
0.51
3.4
2.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
513
4907
1.05
0.51
1.6
1.6
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
28
347
0.81
0.50
1.1
1.1
%
99.6
97.0
0.23
28
331
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
52
444
1.17
0.50
1.4
1.4
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
6
41
1.46
0.50
1.2
1.3
%
18.2
23.9
—
6
30
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
6
41
1.46
0.50
1.0
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
41
343
1.20
0.50
1.8
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
58
501
1.16
0.49
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
157
1442
1.09
0.49
3.4
2.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
111
1002
1.11
0.49
4.1
4.0
mmol/l
24.9
24.8
0.04
99
939
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
191
2058
0.92
0.49
1.4
1.4
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
7
45
1.56
0.49
1.4
1.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
104
936
1.11
0.49
1.6
1.6
iu/ml
0.8
6.8
0.43
25
183
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
110
0.64
0.48
1.1
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
110
0.64
0.48
1.0
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
75
662
1.14
0.48
1.3
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
12
85
1.41
0.46
4.5
12.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
64
561
1.14
0.46
4.7
6.1
iu/ml
962.4
710.6
—
9
80
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
39
328
1.19
0.46
1.2
1.4
pmol/l
1150.7
299.7
0.59
31
257
(3035947) Staphylolysin Ab [Units/volume] in Serum
16
120
1.33
0.46
1.3
1.1
—
4.3
—
0
6
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
253
2378
1.07
0.46
2.1
1.9
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
52
600
0.86
0.45
1.9
2.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
25
201
1.25
0.45
1.2
1.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
25
201
1.25
0.45
1.6
2.3
u/field
0.8
2.0
1.78
16
92
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
15
112
1.34
0.44
1.5
2.3
ug/l
0.9
1.5
0.75
15
103
(3027944) Amphetamines [Presence] in Urine
153
1413
1.09
0.44
1.7
2.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
51
1.37
0.44
1.1
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
51
1.37
0.44
1.3
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
78
696
1.12
0.44
1.4
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
57
498
1.15
0.43
1.5
1.4
u/l
27.9
25.0
0.23
45
413
(3008295) Osmolality of Serum or Plasma
33
275
1.20
0.43
2.7
1.4
mosm/kgh2o
286.4
281.3
0.42
24
214
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
57
650
0.87
0.43
1.2
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
20
157
1.28
0.43
1.8
1.3
nmol/l
132.3
133.2
0.05
20
157
(3026389) Candida sp identified in Specimen by Organism specific culture
44
377
1.17
0.43
1.4
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
11
78
1.41
0.43
1.5
1.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
29
239
1.22
0.42
1.4
1.4
e6/l
1530.7
2505.2
0.78
20
167
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
56
1.43
0.42
5.5
7.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
32
1.56
0.42
1.2
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
25
203
1.23
0.42
1.5
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
20
158
1.27
0.41
1.3
1.4
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
20
158
1.27
0.41
1.5
1.6
umol/l
27.2
26.1
0.06
20
150
(3020779) Urea [Moles/volume] in Serum or Plasma
234
2204
1.07
0.41
6.3
7.8
mmol/l
8.2
9.0
1.19
223
2111
(3028717) Thiamine [Mass/volume] in Blood
5
33
1.52
0.41
1.2
1.3
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3013762) Body weight Measured
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
17
0.00
0.40
0.0
3.4
—
—
—
0
0
(3036603) Volume of Urine
22
177
1.24
0.40
2.1
1.4
ml
1674.4
2084.6
—
10
35
(3000330) Specific gravity of Urine by Test strip
112
1221
0.91
0.40
3.6
3.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
18
141
1.28
0.40
1.1
1.8
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
8
61
1.31
0.39
1.1
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
103
0.68
0.39
1.9
2.6
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
19
0.00
0.39
0.0
3.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
47
538
0.87
0.39
2.8
3.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
37
316
1.17
0.38
1.1
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
33
279
1.18
0.38
1.6
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
30
356
0.84
0.38
2.3
2.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
139
1289
1.08
0.38
10.5
10.8
mmol/l
24.6
24.3
0.54
133
1214
(3029075) Extractable nuclear Ab panel - Serum
11
80
1.38
0.38
1.3
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
11
80
1.38
0.38
1.3
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
28
334
0.84
0.38
1.1
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
62
552
1.13
0.38
2.4
3.0
umol/l
32.1
36.8
0.93
52
477
(3051611) Lipemic interference index of Serum or Plasma
30
252
1.19
0.37
3.2
3.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
36
308
1.17
0.37
1.2
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
37
1.35
0.37
6.4
3.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
15
116
1.29
0.37
2.0
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
15
116
1.29
0.37
2.0
2.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
15
116
1.29
0.37
1.2
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
71
1.27
0.36
1.2
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
33
385
0.86
0.36
2.7
3.1
nmol/l
0.9
0.8
0.15
27
303
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
22
180
1.22
0.36
1.1
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
42
366
1.15
0.35
1.4
1.6
—
—
—
0
0
(4281824)
23
277
0.83
0.35
1.1
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
122
0.74
0.35
4.8
3.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
15
117
1.28
0.35
2.1
2.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
44
1.36
0.34
1.3
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
70
633
1.11
0.34
1.7
1.7
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
138
1288
1.07
0.34
2.6
2.8
e6/l
0.4
0.3
0.11
132
1249
(3051651) Icteric interference index of Serum or Plasma
20
163
1.23
0.34
2.5
3.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
100
921
1.09
0.34
3.4
3.4
g/l
0.2
0.3
1.19
54
411
(3028308) Erythrocytes [#/volume] in Pleural fluid
25
209
1.20
0.34
1.5
1.4
e6/l
35312.8
112399.1
1.11
16
124
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
12
91
1.32
0.33
2.0
2.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
69
761
0.90
0.33
1.5
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
76
833
0.91
0.32
1.4
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
30
257
1.17
0.32
1.2
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
57
633
0.90
0.31
1.3
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
26
220
1.18
0.31
1.2
1.5
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
22
183
1.20
0.31
1.0
1.1
nmol/l
0.1
6.2
—
5
37
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
108
1003
1.08
0.31
3.4
3.9
%
51.6
49.6
0.34
108
990
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
53
590
0.90
0.31
1.5
1.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
96
0.73
0.30
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
7
98
0.71
0.30
1.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
10
131
0.76
0.30
1.1
2.1
ug/l
18.9
80.0
—
10
117
(3004716) Salmonella sp identified in Stool by Organism specific culture
174
1646
1.06
0.30
1.3
1.4
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
13
102
1.28
0.30
1.0
4.1
mg/l
290.3
64.6
—
6
73
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
77
837
0.92
0.29
1.4
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
71
650
1.09
0.29
1.7
1.7
—
—
—
0
0
(3017704) Immunofixation for Urine
17
139
1.22
0.29
1.3
1.6
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
7
57
1.23
0.29
1.0
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
77
836
0.92
0.28
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
77
835
0.92
0.28
1.4
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
8
62
1.29
0.28
1.9
2.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
11
85
1.30
0.28
1.2
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
194
0.82
0.27
1.1
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
81
749
1.08
0.27
1.6
1.9
iu/l
5.1
4.7
0.11
26
272
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
56
509
1.10
0.27
1.3
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
97
1038
0.93
0.26
1.8
1.8
g/l
1.4
1.5
0.76
85
906
(3026692) Albumin [Mass/volume] in Peritoneal fluid
5
71
0.70
0.26
5.0
1.5
g/l
13.5
12.8
—
5
52
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
33
291
1.14
0.26
1.4
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
84
903
0.93
0.25
1.4
1.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
10
127
0.79
0.25
1.5
1.6
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
21
179
1.17
0.25
1.3
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
26
226
1.15
0.24
1.1
1.2
—
275.0
—
0
6
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
10
78
1.28
0.24
1.0
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
24
208
1.15
0.24
1.4
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
19
222
0.86
0.23
1.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
53
578
0.92
0.23
1.3
1.7
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
5
38
1.32
0.23
6.2
2.8
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
38
1.32
0.23
1.0
1.4
ng/l
50.5
111.6
—
5
38
(3008757) Leukocyte morphology finding [Identifier] in Blood
31
275
1.13
0.23
2.6
4.3
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
22
190
1.16
0.23
1.1
1.1
u/ml
0.5
1.3
—
7
54
(44806071)
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
40
1.25
0.22
6.6
8.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
93
0.75
0.22
1.0
1.6
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
23
200
1.15
0.22
1.7
1.5
—
68.2
—
0
21
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
17
144
1.18
0.22
2.0
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
17
144
1.18
0.22
2.0
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
17
144
1.18
0.22
2.0
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
17
144
1.18
0.22
2.0
2.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
11
135
0.81
0.22
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
22
191
1.15
0.21
1.5
1.5
—
—
—
0
0
(4306422)
44
482
0.91
0.21
1.2
1.2
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
11
0.00
0.21
0.0
1.0
—
8.3
—
0
11
(3006598) pH of Arterial cord blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
3.8
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
1.4
—
0
10
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
10
0.00
0.21
0.0
1.0
—
2.5
—
0
10
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
65
604
1.08
0.21
2.3
2.6
ug/min
75.0
121.3
0.64
35
377
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
0
12
0.00
0.21
0.0
1.7
—
21.7
—
0
6
(3001019) Free T4 and TSH panel - Serum or Plasma
174
1814
0.96
0.21
1.6
1.7
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
43
1.16
0.21
1.4
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
15
177
0.85
0.21
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
92
867
1.06
0.21
1.1
1.2
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
4947.0
—
0
7
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
52
479
1.09
0.21
1.1
1.1
iu/ml
17.8
1217.0
0.55
17
112
(1761868) Lipid panel - Serum or Plasma
1104
10897
1.02
0.20
2.6
2.6
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
14
0.00
0.20
0.0
5.0
—
412.7
—
0
14
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
32
288
1.11
0.20
2.2
2.2
pg
33.6
32.2
0.97
32
288
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
70
655
1.07
0.19
1.2
1.4
e6/l
7.1
20.0
1.35
56
501
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
70
655
1.07
0.19
1.2
1.4
e6/l
355.4
1324.1
1.05
61
526
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
17
146
1.17
0.19
1.2
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
17
146
1.17
0.19
1.2
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
152
1584
0.96
0.19
1.5
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
91
861
1.06
0.19
1.1
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
72
676
1.07
0.19
1.7
1.7
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
81
1.24
0.18
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
81
1.24
0.18
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
313
3048
1.03
0.18
1.8
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
24
269
0.89
0.18
1.5
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
90
853
1.06
0.18
1.1
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
59
1.19
0.18
1.4
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
14
119
1.18
0.17
1.4
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24
214
1.12
0.17
2.1
2.7
e6/l
428.7
714.0
—
9
87
(4015189)
7
63
1.11
0.17
1.3
2.8
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
51
475
1.07
0.17
1.2
1.2
u/ml
2.8
4.8
1.39
26
202
(3036782) Glucose [Moles/volume] in Pleural fluid
23
205
1.12
0.17
1.4
1.4
mmol/l
4.8
6.4
1.60
23
191
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
39
359
1.09
0.16
1.3
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
10
120
0.83
0.16
1.4
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
345
3371
1.03
0.16
1.5
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
735
7245
1.02
0.16
1.6
1.6
mmol/l
1.4
1.4
0.29
642
6171
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
25
225
1.11
0.16
1.2
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
73
1.10
0.15
1.3
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
27
245
1.10
0.15
1.8
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
27
245
1.10
0.15
1.8
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
27
245
1.10
0.15
1.8
1.7
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
9
80
1.13
0.15
1.1
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
26
236
1.10
0.14
1.2
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
129
0.85
0.14
1.1
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
47
502
0.94
0.14
1.1
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
22
244
0.90
0.14
1.3
1.4
pmol/l
68.0
174.7
0.42
12
78
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
41
440
0.93
0.14
1.1
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
42
450
0.93
0.14
2.6
3.1
mmol/l
6.7
7.4
1.69
42
437
(44790048)
29
316
0.92
0.14
1.8
1.5
—
—
—
0
0
(44790049)
29
316
0.92
0.14
1.8
1.5
—
—
—
0
0
(44790047)
29
316
0.92
0.14
1.8
1.5
—
—
—
0
0
(44806118)
29
316
0.92
0.14
1.8
1.5
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
14
160
0.87
0.14
1.0
1.0
ng/l
17.6
42.2
—
9
97
(3020891) Body temperature
102
979
1.04
0.14
4.5
4.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
96
0.83
0.13
1.0
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
100
0.80
0.13
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
33
305
1.08
0.13
1.1
1.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
17
151
1.13
0.13
1.5
2.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
63
598
1.05
0.13
1.4
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
818
8090
1.01
0.13
1.5
1.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
106
0.85
0.13
1.3
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
9
107
0.84
0.13
1.7
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
334
3404
0.98
0.13
1.3
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
94
977
0.96
0.12
1.3
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
44
414
1.06
0.12
1.5
1.4
—
—
—
0
0
(3012565) Volume of 24 hour Urine
15
133
1.13
0.12
3.5
2.7
ml
1953.7
1955.9
0.00
15
120
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
17
189
0.90
0.12
1.1
1.1
ratio
1.1
1.0
—
5
74
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
162
1.11
0.11
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
55
578
0.95
0.11
4.6
4.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
12
105
1.14
0.11
1.2
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
186
1819
1.02
0.10
3.1
3.3
kpa
4.7
4.6
0.16
181
1758
(3013293) Extractable nuclear Ab [Presence] in Serum
5
44
1.14
0.10
1.0
1.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
87
1.15
0.09
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
16
176
0.91
0.09
1.3
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
42
442
0.95
0.09
1.0
1.1
u/ml
1.5
2.7
1.02
23
215
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
48
1.04
0.09
1.0
3.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
65
625
1.04
0.09
6.2
3.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
32
301
1.06
0.09
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
176
1723
1.02
0.09
2.8
2.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
218
2220
0.98
0.09
3.6
4.0
mmol/l
1.9
2.0
0.12
182
1791
(3008536) Aspergillus sp Ab [Presence] in Serum
6
58
1.03
0.08
3.5
2.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
63
607
1.04
0.08
1.4
1.4
—
20.6
—
0
13
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
53
552
0.96
0.08
1.5
1.4
u/ml
103.1
116.0
0.51
19
110
(3028679) Herpes simplex virus Ab [Presence] in Serum
20
185
1.08
0.08
1.3
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
59
612
0.96
0.08
1.4
1.2
u/ml
254.2
266.1
0.09
35
374
(3044007) Cell count panel - Peritoneal fluid
6
72
0.83
0.07
1.7
2.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
37
388
0.95
0.07
3.0
3.6
%
0.9
1.3
1.00
32
314
(3008037) Lactate [Moles/volume] in Venous blood
46
479
0.96
0.07
2.5
3.0
mmol/l
1.3
1.5
1.57
46
462
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
50
481
1.04
0.07
1.2
1.2
u/ml
2.2
4.0
1.20
12
159
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
23
245
0.94
0.07
4.2
4.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
314
3103
1.01
0.07
7.0
7.4
mmol/l
104.6
104.5
0.13
309
3041
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
87
1.03
0.07
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
9
87
1.03
0.07
1.2
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
95
0.84
0.06
1.0
1.7
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
21
223
0.94
0.06
3.0
3.1
mg/l
62.7
41.7
0.26
14
166
(3021447) Carbon dioxide [Partial pressure] in Venous blood
220
2227
0.99
0.05
3.5
4.0
kpa
5.9
5.9
0.60
215
2158
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
123
1209
1.02
0.05
3.7
4.3
mmol/l
24.4
24.2
0.31
111
1099
(3014271) Vancomycin [Susceptibility]
11
100
1.10
0.05
2.6
2.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
23
218
1.06
0.05
1.7
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
110
0.91
0.05
1.3
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
123
1210
1.02
0.05
1.6
1.8
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
44
426
1.03
0.05
4.0
5.4
umol/l
356.3
369.8
0.33
39
375
(3032773) Endomysium IgG Ab [Titer] in Serum
24
252
0.95
0.05
1.0
1.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2479
24829
0.99
0.04
17.8
16.1
g/l
332.7
332.9
0.26
2463
24648
(3020491) Glucose [Moles/volume] in Blood
19
201
0.94
0.04
1.8
1.9
mmol/l
7.2
6.7
0.23
14
137
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
47
457
1.03
0.04
1.8
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
170
1.06
0.04
1.2
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
25
261
0.96
0.04
1.9
2.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
12
111
1.08
0.04
1.0
1.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
42
408
1.03
0.04
1.4
1.4
mmol/l
58.7
65.8
0.49
34
329
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
151
1.06
0.03
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
12
112
1.07
0.03
1.8
1.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
11
118
0.93
0.02
3.4
2.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
51
500
1.02
0.02
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
123
1218
1.01
0.02
1.4
1.7
mg/l
3.4
4.1
0.41
83
850
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
32
312
1.03
0.02
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
19
197
0.96
0.01
1.7
2.2
—
—
—
0
0
(3004451) EKG impression Narrative
13
124
1.05
0.00
1.5
1.3
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
13
136
0.96
0.00
2.1
3.2
—
32.4
—
0
12
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
14
146
0.96
0.00
1.0
1.3
%
—
77.0
—
0
18
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
15
156
0.96
0.00
1.7
1.4
mmol/l
5.3
5.7
0.88
15
150
(3011648) Oxygen content in Venous blood
21
204
1.03
0.00
2.1
2.7
%
10.5
11.4
0.38
21
204
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
40
406
0.99
0.00
1.7
1.3
mmol/l
6.8
7.2
0.38
32
300
(3047189) Immunofixation for 24 hour Urine
11
112
0.98
0.00
2.6
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
118
1.02
0.00
1.6
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
118
1.02
0.00
1.6
1.7
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
21
205
1.02
0.00
1.3
1.3
—
1.5
—
0
10
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
25
245
1.02
0.00
1.4
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
18
181
0.99
0.00
1.9
1.8
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
24
239
1.00
0.00
2.6
3.4
%
49.5
56.1
0.67
17
163
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
38
379
1.00
0.00
1.2
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
41
409
1.00
0.00
1.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
64
644
0.99
0.00
1.3
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
19
186
1.02
0.00
2.7
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
48
476
1.01
0.00
1.5
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
110
1097
1.00
0.00
1.4
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
103
1033
1.00
0.00
1.4
1.4
—
—
—
0
0
(4027681)
21
207
1.01
0.00
1.1
1.2
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.8
—
46.4
—
0
8
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
8
0.00
0.00
0.0
4.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
170.3
—
0
6
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
51
0.98
0.00
1.0
1.2
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
51
0.98
0.00
1.0
1.2
—
—
—
0
0
(3047185) IgG [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
51
0.98
0.00
1.0
1.2
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
56
0.89
0.00
1.2
1.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
52
0.96
0.00
1.8
2.8
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
9
0.00
0.00
0.0
1.9
—
2626.6
—
0
9
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
72
0.97
0.00
1.3
2.2
umol/l
13.4
16.6
—
7
72
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
83
0.96
0.00
1.1
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
73
0.96
0.00
1.3
2.9
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
4.4
—
4.5
—
0
7
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
56
0.89
0.00
1.4
1.4
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
49
1.02
0.00
1.4
3.0
mmol/l
1.2
1.2
—
5
49
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
91
0.99
0.00
1.2
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
65
0.92
0.00
1.0
1.1
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
7
0.00
0.00
0.0
6.6
—
96.3
—
0
7
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
73
0.96
0.00
1.3
2.9
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
55
0.91
0.00
1.0
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
90
1.00
0.00
2.9
3.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_BONE_CARTILAGE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_BONE_CARTILAGE | 1.057 [0.93, 1.21] | 0.407 |
| Birth year | 0.999 [0.99, 1.01] | 0.714 |
During the follow-up period (1.1.1998 — 31.12.2019), 530 out of 7903 females with CD2_BENIGN_BONE_CARTILAGE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_BONE_CARTILAGE | 1.056 [0.93, 1.2] | 0.408 |
| Birth year | 0.987 [0.98, 1.0] | 0.007 |
During the follow-up period (1.1.1998 — 31.12.2019), 589 out of 7613 males with CD2_BENIGN_BONE_CARTILAGE died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_BONE_CARTILAGE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.093% | 0.165% |
| 5 | 0.603% | 1.185% |
| 10 | 1.661% | 2.905% |
| 15 | 3.341% | 5.841% |
| 20 | 6.078% | 9.778% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_BONE_CARTILAGE – Benign neoplasm of bone and articular cartilage
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data